Document Detail


Long-term outcome of palliative treatment with self-expanding metal stents for malignant obstructions of the GI tract.
MedLine Citation:
PMID:  23046494     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Background. Self-expanding metal stents (SEMS) are commonly used in the palliative treatment of malignant gastrointestinal (GI) obstructions with favorable short-term outcome. Data on long-term outcome are scarce, however. Aim. To evaluate long-term outcome after palliative stent treatment of malignant GI obstruction. Method. Between October 2006 and April 2008, nine Norwegian hospitals included patients treated with SEMS for malignant esophageal, gastroduodenal, biliary, and colonic obstructions. Patients were followed for at least 6 months with respect to stent patency, reinterventions, and readmissions. Results. Stent placement was technically successful in 229 of 231 (99%) and clinically successful after 1 week in 220 of 229 (96%) patients. Long-term follow-up was available for 219 patients. Of those, 72 (33%) needed reinterventions. Stent occlusions or migrations (92%) were the most common reasons. Esophageal stents required reinterventions most frequently (41%), and had a significantly (p = 0.02) shorter patency (median 152 days) compared to other locations (gastroduodenal, 256 days; colon, 276 days; biliary, 460 days). Eighty percent of reinterventions were repeated endoscopic procedures that successfully restored patency. Readmissions were required for 156 (72%) patients. Progression of the underlying cancer was the most common reason, whereas 24% were readmitted due to stent complications. Conclusions. Long-term outcome after palliative treatment with SEMS for malignant GI and biliary obstruction shows that 70% had a patent stent until death, and that most reobstructions could be solved endoscopically. Hospital readmissions were mainly related to progression of the underlying cancer disease.
Authors:
Lene Larssen; Asle W Medhus; Hartwig Körner; Tom Glomsaker; Taran Søberg; Dagfinn Gleditsch; Oistein Hovde; Jan K Tholfsen; Knut Skreden; Arild Nesbakken; Truls Hauge
Related Documents :
24679654 - Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance trea...
24219814 - Nebulized tobramycin in the treatment of adult cf pulmonary exacerbations.
24380994 - Covered self-expanding stent treatment for anastomotic leakage: outcomes in esophagogas...
23819724 - Discontinuation rates and inter-injection interval for repeated intravesical botulinum ...
24679654 - Recurrence of chronic pulmonary aspergillosis after discontinuation of maintenance trea...
18157674 - Topical steroid application versus circumcision in pediatric patients with phimosis: a ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-10
Journal Detail:
Title:  Scandinavian journal of gastroenterology     Volume:  -     ISSN:  1502-7708     ISO Abbreviation:  Scand. J. Gastroenterol.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0060105     Medline TA:  Scand J Gastroenterol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Gastroenterology, Oslo University Hospital , Ullevål, Oslo , Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of epirubicin hydrochloride and miriplatin hydrate as anticancer agents for transcatheter...
Next Document:  Ranking relations between diseases, drugs and genes for a curation task.